Study in Healthy Participants and Participants With Moderate Atopic Dermatitis & Optionally, Moderate Psoriasis, and/or Mild Asthma

NCT04927195 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Atopic Dermatitis
Psoriasis
Asthma

Interventions

DRUG: EDP1867
DRUG: Placebo

Sponsor

Evelo Biosciences, Inc.